SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-136035
Filing Date
2022-05-02
Accepted
2022-05-02 11:40:56
Documents
14
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d289121ddef14a.htm DEF 14A 919651
2 GRAPHIC g289121g01a50.jpg GRAPHIC 170529
3 GRAPHIC g289121g02z99.jpg GRAPHIC 132869
4 GRAPHIC g289121g41p15.jpg GRAPHIC 20836
5 GRAPHIC g289121g44q12.jpg GRAPHIC 29033
6 GRAPHIC g289121g63s72.jpg GRAPHIC 55233
7 GRAPHIC g289121g75q32.jpg GRAPHIC 30379
8 GRAPHIC g289121g89a01.jpg GRAPHIC 5317
9 GRAPHIC g289121g89b02.jpg GRAPHIC 2047
10 GRAPHIC g289121g89c03.jpg GRAPHIC 1571
11 GRAPHIC g289121g89d04.jpg GRAPHIC 2250
12 GRAPHIC g289121g89e05.jpg GRAPHIC 2566
13 GRAPHIC g289121g90a90.jpg GRAPHIC 1914
14 GRAPHIC g289121g97q10.jpg GRAPHIC 62768
  Complete submission text file 0001193125-22-136035.txt   1616674
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33277 | Film No.: 22880211
SIC: 2834 Pharmaceutical Preparations